Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.

Salzman, S K; Kelly, G; Chavin, J; Wang, L; Puniak, M A; Agresta, C A; Azim, S

Salzman, S K; Kelly, G; Chavin, J; Wang, L; Puniak, M A; Agresta, C A; Azim, S.

Affiliation

Salzman SK; Department of Medical Cell Biology, Alfred I. duPont Institute, Wilmington, Delaware.

J Pharmacol Exp Ther ; 269(1): 322-8, 1994 Apr.

Article in En | MEDLINE | ID: mdl-8169839

Subject(s)

Mianserin/therapeutic use; Spinal Cord Diseases/prevention & control; Spinal Cord Injuries/drug therapy; Animals; Dose-Response Relationship, Drug; Drug Administration Routes; Edema/etiology; Edema/prevention & control; Ketanserin/therapeutic use; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Receptors, Serotonin/classification; Serotonin/metabolism; Serotonin Antagonists; Spinal Cord Diseases/etiology; Spinal Cord Diseases/metabolism; Spinal Cord Injuries/complications; Spinal Cord Injuries/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Spinal Cord Diseases / Spinal Cord Injuries / Mianserin Type of study: Etiology_studies Limits: Animals Language: En Journal: J Pharmacol Exp Ther Year: 1994 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links